Press Releases

Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development

Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility

Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

Piramal Pharma Solutions’ Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch

Piramal Consumer Healthcare’s Tetmosol Announces Pankaj Tripathi as Brand Ambassador; Launches New Campaign and Expands Portfolio

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas

Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities

Little’s gives babies a voice with its new campaign ‘Life is Hard. Switch to Softer’

Piramal Pharma Limited Announces Results for Q3 and 9M FY26

Piramal Pharma Limited’s Consumer Healthcare launches Little’s AquaSense Baby Wipes - 99.9% Water

Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates

Piramal Pharma Limited Announces Results for Q2 and H1 FY26

Piramal Pharma Solutions Formalizes Partnership with IntoCell,Expanding its Payload-Linker Platform and Bioconjugate Capabilities

Riverview, Michigan and Digwal, India Facilities with the Annual Excellence in Patient Centricity Award

Piramal Pharma Solutions’ Aurora, Canada Facility Implements the POD Method to Optimize Project Execution

Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility

Piramal Pharma Publishes FY2025 Sustainability Report, Outlining Performance and Decarbonization Glidepath

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal’s Sellersville, Pennsylvania Site

Piramal Pharma Limited Announces Results for Q1 and FY2026

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Limited Announces Results for Q4 and FY2025

Piramal Pharma Ltd. Continues to Invest in USA; $90M in Expansion of Two US Sites

BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK

Piramal Pharma Limited Announces Results for Q3 and 9M FY25

Piramal Pharma ropes in Yami Gautam as its brand ambassador for Brand,Little’s

Piramal Critical Care Announces U.S. Launch of Chlorpromazine Hydrochloride for Injection, USP

Piramal Pharma Limited Converts the Coal-Fired Steamer at its Digwal Facility to Operate on Biomass Briquettes, Advancing Decarbonization Efforts

Piramal Pharma ropes in Mrunal Thakur as its brand ambassador for Lacto Calamine®

Piramal Pharma Limited Announces Results for Q2 and H1 FY25

Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme Building Resilience for a Sustainable Tomorrow

Capacity Expansion at Piramal Pharma Solutions (‘PPS’) Facility at Lexington, Kentucky

Piramal Pharma’s GHG Commitment Validated and Approved by SBTi

Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work

Piramal Pharma Limited Announces Results for Q1 FY2025

Piramal Pharma Limited Announces Results for Q4 and FY2024

Piramal Pharma Limited (PPL) forays into men’s grooming market in India with the launch of BOHEM

Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024

Piramal Pharma Solutions Commemorates Opening of Its ADC Manufacturing Expansion in Grangemouth, Scotland

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

PPL Result Press Release – Q1FY24

Piramal Critical Care appoints Jeffrey Hampton as President and Chief Operating Officer

PPL Result Press Release – Q4 and FY2023

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials

Piramal Pharma Solutions Supports Theracosbio With Integrated Drug Substance/drug Product Program For Bexagliflozin

Piramal Pharma Solutions Announces Production Of First Batches At New Api Facility In Riverview, Michigan

PPL Result Press Release – Q3 and 9M FY2023

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023

Piramal Pharma Solutions Announces Winner of its September 2022 Award for Excellence in Patient Centricity

Piramal Pharma Limited lists on BSE and NSE

Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics

Piramal Pharma Solutions Launches ADCelerate, a Rapid, Integrated Approach to Taking ADCs to IND

Piramal Pharma unveils its Sustainability Report FY21–22, articulating its ESG journey to accelerate the pace of integrating sustainability practices

Piramal Pharma Appoints Vibha Paul Rishi as Non- Executive Director to its Board of Directors

NCLT approves Piramal Enterprises demerger

Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

Piramal Pharma Ltd Strengthens Board by Inducting Three New Board Members

Piramal Pharma Solutions Appoints Herve Berdou as Chief Operating Officer

Piramal Pharma Solutions Expands API Capabilities at Digwal; Applies Operational Excellence Tools to Release Capacity

Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities with New Production Block at Pithampur Site

Piramal Pharma Solutions New API Plant in Canada Goes Online; Initial Production Runs Successfully Completed

Piramal Pharma Solutions Announces Winner of its Winter 2022 Award for Excellence in Patient Centricity

Piramal Pharma Solutions Strengthens North American Capabilities with Addition of Development/Commercial Scale Roller Compactor at Sellersville, PA Site

Piramal Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO Providing Expertise in Biologics and Vaccines

Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO Providing Expertise in Biologics and Vaccines

Piramal Enterprises Announces Demerger and Simplification of Corporate Structure; To Create Two Separate Listed Entities in Financial Services and Pharmaceuticals

Piramal Pharma Solutions Announces Winner of its Inaugural Award for Excellence in Patient Centricity

Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc.

Piramal Lacto Calamine® Announces Brand Association with Actress Kajal Aggarwal

Piramal Pharma Limited’s Consumer Products Division Launches ‘i-feel®’

Piramal Pharma Limited’s Consumer Products Division Ropes in Manoj Bajpayee for its Skin-Care Soap ‘Tetmosol’

Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-Drug Conjugate

Piramal Pharma Solutions Invests ~$32 Million to Expand its Riverview Michigan Facility for Additional Capacity in Potent and Non-Potent API Development and Manufacturing

Piramal Pharma and Navin Fluorine Mutually Agree on Piramal Increasing its Stake to 100% in Convergence Chemicals

Piramal Pharma Consumer Products Division’s Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute

Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle

Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs

Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish

Piramal Critical Care Announces Strategic Partnership with US-Based Pharmaceutical Outsourcing Facility – Medivant Healthcare

Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment

Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

Piramal Enterprises’ Consumer Products Division Ropes in Sourav Ganguly as the Brand Ambassador for ‘Polycrol’, its Antacid Brand

Piramal Pharma Solutions Invests ~CAD$25 Million to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing

Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment

Piramal Pharma Solutions Expands its High Potency API Capability at Riverview, MI Facility

Piramal Pharma Solutions Transforms Chilkepally Mandal Parishad Primary School through its Community Engagement Programme

Piramal Announces the Launch of Cinacalcet by its partner, Slate Run Pharmaceuticals, in the U.S.

Piramal Critical Care announces the U.S. Launch of Mitigo

Supreme Court Exempts Saridon from the List of Banned FDCs

Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

Piramal Pharma Solutions Recognized as ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2018.

Piramal Pharma Solutions wins in six categories at the ‘CMO Leadership Awards 2018’

Piramal Enterprises Acquires Digeplex and Associated Brands for its Consumer Products Business

Piramal Pharma Solutions wins ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2017

Piramal Pharma Solutions wins at prestigious CPhI Pharma Awards

Piramal Pharma Solutions Announces Large scale Expansion of API Manufacturing Facilities

Piramal Enterprises Consumer Products Division Launches Garden Sciencz by Jungle Magic

Tollywood superstar and Polycrol Brand Ambassador, Prosenjit Chatterjee celebrates Maha Ashtami with his fans

Piramal Pharma Solutions names John Fowler as its Chief Operating Officer

Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC

Piramal’s Consumer Products Division launches new variants of heritage Brand Lacto Calamine

Piramal Enterprises Introduces ‘Paan’ flavour for its Leading Antacid Brand ‘Polycrol’; Ropes in Indian Film Actor Prosenjit Chatterjee as its Brand Ambassador for Eastern India

Piramal Enterprises Introduces ‘Paan’ flavour for its Leading Antacid Brand ‘Polycrol’; Ropes in Bollywood Actor Manoj Bajpayee as its Brand Ambassador

Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care

Piramal Pharma Solutions augments integrated capabilities by expanding sterile manufacturing capabilities in Lexington, KY

Piramal Pharma Solutions names Stuart E. Needleman as Chief Commercial Officer

Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen’s injectable anesthesia and pain management products

Piramal Enterprises receives ‘Silver Award’ for iCan at the APPIES APAC Awards

Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)

Piramal Pharma Solutions expands capacity for sterile manufacturing in Lexington

Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business

Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.

Piramal Enterprises launches India’s first ever Benzocaine based throat spray* – Throatsil

Piramal critical care and cumberland pharmaceuticals Announce launch of caldolor and vaprisol co-promotion

Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business

Piramal healthcare invests £2.0 mn in scotland

Piramal Enterprises acquires the Baby Care Brand – Little’s for the Consumer Products Business

Cumberland pharmaceuticals and piramal enterprises Announce co-promotion agreement

Piramal Pharma Solutions receives ‘API Supplier of the Year’ award at Global Generics and Biosimilar Award 2015

Piramal Pharma Solutions, CEO Vivek Sharma receives ‘CEO of the Year’ award at CPhI Awards 2015

Piramal targets becoming the global market leader in development & manufacturing of Antibody Drug Conjugates (ADCs)

Piramal encourages pharma to embrace green chemistry ahead of CPhI

Piramal Healthcare launches Stop AllerG in the allergy segment

Piramal Enterprises renames its ovulation test kit brand as “i-know”

Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

Piramal Enterprises’ Pharma Solution division receives four CMO Leadership Awards 2015

Piramal Enterprises’ Consumer Product division ropes in Juhi Chawla as brand ambassador for their brand ‘Jungle Magic’

Piramal Enterprises ropes in Sharman Joshi as brand ambassador for their latest OTC product offering -‘QuikKool’

Piramal Enterprises’ Pharma Solution Division receives two coveted CMO Leadership Awards (2013) for “Quality ” and “Reliability “

Piramal Enterprises acquires the brand CALADRYL ? in India

Five Star Safety Ratings awarded to Piramal Enterprises Ltd. by British Safety Council

Piramal | Healthcare to invest $ 11 million in hormonal healthcare production at its Morpeth, UK, facility

Piramal’s healthcare vertical invests USD $2.5 million to further expand commercial ADC capacity

Piramal Enterprises’ expands its Jungle Magic portfolio with the launch of Banditz

Piramal Enterprise celebrates the enduring beauty of “Audrey Hepburn” with the launch of, “Lacto Calamine RENEU”, an all new anti-ageing cream

Piramal Healthcare announces settlement of patent litigation with Baxter Halthcare related to generic version of SUPRANE (Desflurane)

Piramal Healthcare Limited to acquire the Anesthetic products business of Bharat Serums And Vaccines Limited

Piramal Healthcare Limited Acquires U.S. Inhalation Anesthetic Gas Distribution Business of RxElite, Inc.

Piramal Healthcare Limited Completes Acquisition of Minrad International, Inc.